Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease

[1] Klocke FJ(2003)ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) Circulation 108 1404-1418

[2] Baird MG(2006)Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats J Pharmacol Exp Ther 316 695-702

[3] Lorell BH(2009)Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus Am Heart J 157 771-776

[4] Bateman TM(2003)Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study Circulation 107 2894-2899

[5] Messer JV(2005)A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy J Am Coll Cardiol 45 722-729

[6] Berman DS(2010)Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging J Nucl Cardiol 17 617-624

[7] Dhalla AK(2009)Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease Am J Cardiol 103 1159-1164

[8] Wong MY(2013)Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress Am J Cardiol 111 190-195

[9] Wang WQ(2011)The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease Am Heart J 162 356-362

[10] Biaggioni I(2005)Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms Am Heart J 95 1159-1164

[1] Klocke FJ(2003)ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) Circulation 108 1404-1418

[2] Baird MG(2006)Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats J Pharmacol Exp Ther 316 695-702

[3] Lorell BH(2009)Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus Am Heart J 157 771-776

[4] Bateman TM(2003)Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study Circulation 107 2894-2899

[5] Messer JV(2005)A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy J Am Coll Cardiol 45 722-729

[6] Berman DS(2010)Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging J Nucl Cardiol 17 617-624

[7] Dhalla AK(2009)Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease Am J Cardiol 103 1159-1164

[8] Wong MY(2013)Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress Am J Cardiol 111 190-195

[9] Wang WQ(2011)The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease Am Heart J 162 356-362

[10] Biaggioni I(2005)Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms Am Heart J 95 1159-1164